2024-10-01 2025-10-31 false Capium Accounts Production 1.1 15991127 2024-10-01 2025-10-31 15991127 bus:FullAccounts 2024-10-01 2025-10-31 15991127 bus:FRS102 2024-10-01 2025-10-31 15991127 bus:AuditExemptWithAccountantsReport 2024-10-01 2025-10-31 15991127 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-10-31 15991127 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-10-31 15991127 2024-10-01 2025-10-31 15991127 2025-10-31 15991127 bus:RegisteredOffice 2024-10-01 2025-10-31 15991127 core:WithinOneYear 2025-10-31 15991127 core:AfterOneYear 2025-10-31 15991127 1 2024-10-01 2025-10-31 15991127 bus:Director1 2024-10-01 2025-10-31 15991127 bus:Director1 2025-10-31 15991127 2023-10-01 15991127 bus:LeadAgentIfApplicable 2024-10-01 2025-10-31 15991127 2024-09-30 15991127 core:FurnitureFittings 2024-10-01 2025-10-31 15991127 core:FurnitureFittings 2025-10-31 15991127 core:FurnitureFittings 2024-09-30 15991127 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-10-31 15991127 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-09-30 15991127 core:CostValuation core:Non-currentFinancialInstruments 2025-10-31 15991127 core:CostValuation core:Non-currentFinancialInstruments 2024-09-30 15991127 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-10-31 15991127 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-10-31 15991127 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-10-31 15991127 core:Non-currentFinancialInstruments 2025-10-31 15991127 core:Non-currentFinancialInstruments 2024-09-30 15991127 core:ShareCapital 2025-10-31 15991127 core:RetainedEarningsAccumulatedLosses 2025-10-31 15991127 dpl:Item1 2024-10-01 15991127 dpl:Item1 2025-10-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 15991127
England and Wales
BREAST ONCOLOGY & AESTHETICS LTD
Unaudited Financial Statements
Period of accounts Start date: 01 October 2024 End date: 31 October 2025

Breast Oncology & Aesthetics Ltd Contents Page For the Period 01 October 2024 to 31 October 2025
Company Information | 1
Statement of Financial Position | 2
Notes to the Financial Statements | 3

Breast Oncology & Aesthetics Ltd Company Information For the Period 01 October 2024 to 31 October 2025
Director | Panagiotis Pikoulas
Registered Number | 15991127
Registered Office | First Floor, 40 Vicarage Road Edgbaston Birmingham B15 3EZ
Accountants | Marneros Marcus & Co Limited First Floor Hagley Court 40 Vicarage Road Edgbaston Birmingham B153EZ
1

Registered Number: 15991127 Breast Oncology & Aesthetics Ltd Statement of Financial Position As at 31 October 2025
| Notes | 2025 £
--- | --- | ---
Fixed assets |  |
Tangible fixed assets | 3 | 762
|  | 762
Current assets |  |
Cash at bank and in hand |  | 5,130
Creditors: amount falling due within one year | 4 | (2,734)
Net current assets |  | 2,396
Total assets less current liabilities |  | 3,158
Net assets |  | 3,158
Capital and reserves |  |
Called up share capital |  | 100
Profit and loss account |  | 3,058
Shareholders' funds |  | 3,158
For the period ended 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's responsibilities: The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies. The financial statements were approved by the director on 01 July 2026 and were signed by:
------------------------------- Panagiotis Pikoulas Director
2

Breast Oncology & Aesthetics Ltd Notes to the Financial Statements For the Period 01 October 2024 to 31 October 2025
General Information Breast Oncology & Aesthetics Ltd is a private company, limited by shares, registered in England and Wales, registration number 15991127, registration address First Floor, 40 Vicarage Road, Edgbaston, Birmingham, B15 3EZ. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. Taxation Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Current and deferred tax assets and liabilities are not discounted Tangible fixed assets Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Fixtures and Fittings | 25% Straight Line
2. | Average number of employees Average number of employees during the period was 2.
3. | Tangible fixed assets
Cost or valuation | Fixtures and Fittings |  | Total
| £ |  | £
At 01 October 2024 | - |  | -
Additions | 1,016 |  | 1,016
Disposals | - |  | -
At 31 October 2025 | 1,016 |  | 1,016
Depreciation
At 01 October 2024 | - |  | -
Charge for period | 254 |  | 254
On disposals | - |  | -
At 31 October 2025 | 254 |  | 254
Net book values
Closing balance as at 31 October 2025 | 762 |  | 762
Opening balance as at 01 October 2024 | - |  | -
4. | Creditors: amount falling due within one year
| 2025 £
--- | ---
Trade Creditors | 360
Corporation Tax | 1,012
Directors' Current Accounts | 1,362
| 2,734
3